(Q36829303)

16 August 2017

1 reference

title

Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors (English)

1 reference

16 August 2017

1 reference

Maarten G Lansberg

1

1 reference

16 August 2017

Gregory W Albers

series ordinal

2

1 reference

16 August 2017

Christine A C Wijman

series ordinal

3

1 reference

16 August 2017

publication date

22 May 2007

1 reference

16 August 2017

published in

Cerebrovascular Diseases

1 reference

16 August 2017

volume

24

1 reference

16 August 2017

issue

1

1 reference

16 August 2017

page(s)

1-10

1 reference

Tissue plasminogen activator for acute ischemic stroke

16 August 2017

cites work

1 reference

Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association

21 January 2018

1 reference

Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association

21 January 2018

1 reference

Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials

21 January 2018

1 reference

Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data

21 January 2018

1 reference

Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study

21 January 2018

1 reference

Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey

21 January 2018

1 reference

Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume

21 January 2018

1 reference

Lack of clinical significance of early ischemic changes on computed tomography in acute stroke

21 January 2018

1 reference

Acetylsalicylic acid pretreatment, concomitant heparin therapy and the risk of early intracranial hemorrhage following systemic thrombolysis for acute ischemic stroke

21 January 2018

1 reference

Metalloproteinases and their inhibitors in matrix remodeling

21 January 2018

1 reference

Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke.

21 January 2018

1 reference

Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke.

21 January 2018

1 reference

Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis

21 January 2018

1 reference

Thrombolysis for ischemic stroke in patients with old microbleeds on pretreatment MRI.

21 January 2018

1 reference

Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke

21 January 2018

1 reference

Predictors of hyperacute clinical worsening in ischemic stroke patients receiving thrombolytic therapy.

21 January 2018

1 reference

Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients

21 January 2018

1 reference

Thrombolysis in stroke patients aged 80 years and older: Swiss survey of IV thrombolysis

21 January 2018

1 reference

Brain hemorrhage after thrombolysis: good or bad?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000103110

1 reference

16 August 2017

1 reference